Overview

BEYOND Pilot Study

Status:
Completed
Trial end date:
2003-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to valuate safety and tolerability of Betaseron.
Phase:
Phase 2
Details
Lead Sponsor:
Bayer
Treatments:
Interferon beta-1b
Interferon-beta
Interferons